Literature DB >> 21158918

Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.

Marie Ecochard1, Olivier Boillot, Olivier Guillaud, Sabine Roman, Mustapha Adham, François Mion, Jérôme Dumortier.   

Abstract

BACKGROUND: Allocation of graft in liver transplantation (LT) depends mainly on Model for End Stage Liver Disease (MELD) score. We studied the prognostic ability of three metabolic liver function tests in 560 cirrhotic patients listed for transplantation, in comparison with MELD and Child-Turcotte-Pugh (CTP) scores.
METHODS: Indocyanine green retention rate (ICG), aminopyrine breath test (ABT), and galactose elimination capacity were performed at the time of listing in addition to standard biological parameters. Seventy-three patients died on waiting list, 438 were transplanted, and 73 died after LT. Cox regression analysis and receiver operating characteristic curves with c-statistics were calculated after stratification according to CTP and MELD score.
RESULTS: For the mortality before transplantation, c-statistics showed that ICG and ABT had a slightly better prognostic ability (0.73 and 0.68, respectively) than MELD score (0.66), and similar to CTP score (0.70). ABT's prognostic ability remained significant once the MELD score (below and above 20) had already been taken into account. Only ICG had a prognostic ability to predict the survival after LT, even after stratification according to MELD and CTP score.
CONCLUSIONS: Our results strongly support that ABT and ICG may be useful in the ranking of the patients in LT list, adding prognosis information in association with MELD score.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21158918     DOI: 10.1111/j.1399-0012.2010.01366.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis.

Authors:  Edoardo G Giannini; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2013-07-02       Impact factor: 3.199

Review 2.  Advantages of using indocyanine green in liver transplantation: a narrative review.

Authors:  Bo Dai; Nida El Islem Guissi; Lydia Frenzel Sulyok; Mitchell G Bryski; Yiqing Wang; Dongjin Wang; Sunil Singhal; Huiming Cai
Journal:  Ann Transl Med       Date:  2022-01

Review 3.  Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Ying Peng; Xingshun Qi; Xiaozhong Guo
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

4.  Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis.

Authors:  Tomasz Dziodzio; Robert Öllinger; Wenzel Schöning; Antonia Rothkäppel; Radoslav Nikolov; Andrzej Juraszek; Paul V Ritschl; Martin Stockmann; Johann Pratschke; Maximilian Jara
Journal:  BMC Gastroenterol       Date:  2020-08-12       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.